TSS
BMY icon

Two Sigma Securities’s Bristol-Myers Squibb BMY Stock Holding History

Two Sigma Securities’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-201,900
Closed -$10.4M – 1789
2024
Q3 		$10.4M Sell
201,900
-184,600
-48% -$8.66M 0.18% 151
2024
Q2 		$16.1M Buy
386,500
+150,300
+64% +$6.73M 0.19% 106
2024
Q1 		$12.8M Sell
236,200
-77,500
-25% -$3.95M 0.12% 190
2023
Q4 		$16.1M Buy
313,700
+122,000
+64% +$6.4M 0.16% 138
2023
Q3 		$11.1M Buy
191,700
+139,600
+268% +$8.55M 0.12% 185
2023
Q2 		$3.33M Sell
52,100
-6,000
-10% -$402K 0.05% 411
2023
Q1 		$4.03M Sell
58,100
-38,200
-40% -$2.69M 0.08% 296
2022
Q4 		$6.93M Buy
96,300
+46,700
+94% +$3.52M 0.21% 94
2022
Q3 		$3.53M Buy
49,600
+2,600
+6% +$189K 0.11% 226
2022
Q2 		$3.62M Sell
47,000
-11,700
-20% -$891K 0.13% 172
2022
Q1 		$4.29M Buy
58,700
+52,400
+832% +$3.52M 0.15% 155
2021
Q4 		$393K Buy
6,300
+2,100
+50% +$123K 0.02% 664
2021
Q3 		$249K Sell
4,200
-28,900
-87% -$1.9M 0.01% 1100
2021
Q2 		$2.21M Buy
33,100
+23,000
+228% +$1.5M 0.07% 216
2021
Q1 		$638K Sell
10,100
-41,100
-80% -$2.56M 0.04% 233
2020
Q4 		$3.18M Buy
51,200
+31,400
+159% +$1.93M 0.08% 165
2020
Q3 		$1.19M Sell
19,800
-35,600
-64% -$2.14M 0.02% 308
2020
Q2 		$3.26M Sell
55,400
-68,300
-55% -$4.09M 0.07% 150
2020
Q1 		$6.89M Sell
123,700
-176,400
-59% -$10.8M 0.16% 77
2019
Q4 		$19.3M Buy
300,100
+107,100
+55% +$6.13M 0.13% 107
2019
Q3 		$9.79M Sell
193,000
-73,500
-28% -$3.45M 0.09% 168
2019
Q2 		$12.1M Buy
266,500
+255,600
+2,345% +$11.9M 0.13% 102
2019
Q1 		$520K Sell
10,900
-66,900
-86% -$3.33M ﹤0.01% 856
2018
Q4 		$4.04M Sell
77,800
-19,300
-20% -$1.04M 0.05% 196
2018
Q3 		$6.03M Sell
97,100
-218,900
-69% -$13M 0.04% 329
2018
Q2 		$17.5M Buy
316,000
+17,400
+6% +$940K 0.09% 167
2018
Q1 		$18.9M Buy
298,600
+274,100
+1,119% +$17.6M 0.11% 163
2017
Q4 		$1.5M Buy
+24,500
New +$1.53M 0.04% 326

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Two Sigma Securities's BMY Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 4,550 shares worth $262K. The stake represents 0.02% of the portfolio and ranks #978 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in BMY as recently as Q3 2025.

Two Sigma Securities first reported a position in BMY in Q4 2016 and has held it in 29 quarters since. The position peaked at $18.8M in Q3 2023. 2,519 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Two Sigma Securities held 4,550 shares of Bristol-Myers Squibb worth $262K as of Q2 2026.
  • Bristol-Myers Squibb was a new Two Sigma Securities position in Q2 2026.
  • Bristol-Myers Squibb made up 0.02% of Two Sigma Securities's portfolio in Q2 2026, its #978 holding.
  • Two Sigma Securities first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 29 quarters since.
  • Two Sigma Securities's Bristol-Myers Squibb position peaked at $18.8M in Q3 2023.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.